Current Expertise, Opinions, and Attitude toward TNF-⍺ Antagonist Biosimilars among Physicians: A Self-Administered Online Survey in Western Switzerland

Tumor necrosis factor-alpha (TNF-⍺) antagonists are biological drugs with multiple authorized biosimilars. Biosimilars are becoming critical to the financial sustainability of health systems. Recent studies emphasize that physicians’ knowledge regarding biosimilars has not yet progressed sufficientl...

Descripción completa

Detalles Bibliográficos
Autores principales: Krstic, Marko, Devaud, Jean-Christophe, Sadeghipour, Farshid, Marti, Joachim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9690245/
https://www.ncbi.nlm.nih.gov/pubmed/36360497
http://dx.doi.org/10.3390/healthcare10112152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9690245/
https://www.ncbi.nlm.nih.gov/pubmed/36360497
http://dx.doi.org/10.3390/healthcare10112152

Ejemplares similares